Establishment Labs Holdings (ESTA) Net Cash Flow Growth (5y) (2022 - 2026)
Establishment Labs Holdings (ESTA) Net Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | Establishment Labs Holdings | 2.76 Bn | 2.69 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.52% |
| Dec 31, 2025 | 8.24% |
| Sep 30, 2025 | 38.95% |
| Jun 30, 2025 | -16.51% |
| Mar 31, 2025 | -19.10% |
| Dec 31, 2024 | 65.30% |
| Sep 30, 2024 | -27.80% |
| Jun 30, 2024 | -9.96% |
| Mar 31, 2024 | 40.69% |
| Dec 31, 2023 | 0.42% |
| Sep 30, 2023 | -21.92% |
| Jun 30, 2023 | 56.52% |
| Mar 31, 2023 | -40.29% |
| Dec 31, 2022 | -38.31% |
| Sep 30, 2022 | -53.96% |